Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or South Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to South Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. South Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Stephen Parks (NPI 1154387140)

Field	Value
Entity Type	Individual
Organization	Stephen Parks
Address	35 Ray E Talley Ct
City	Simpsonville
State	SC
ZIP	29680
Taxonomy	Family Medicine Physician
NPI Enumerated	April 26, 2006

Payer Source	Total Paid
Medicare	$3.9M
Medicaid	$0

Key Findings

This provider’s billing is overwhelmingly Medicare-driven: lifetime Medicare revenue is $3.9M while there is no Medicaid billing on file, so the entity is effectively a single‑payer (Medicare) operation in the available data. That concentration increases Medicare exposure and means analyses of utilization and reimbursement should focus on Medicare patterns rather than Medicaid comparators.

Revenue is highly concentrated in a small set of biologic and infusion products: J3245 ($759K, 19.5%), J0517 ($510.8K, 13.2%), and J2357 ($472.5K, 12.2%) together account for 44.9% of this provider’s total Medicare revenue. Those three codes alone drive nearly half of reported Medicare payments and should be the primary focus for revenue-risk, contracting, and utilization reviews.

The CPT/HCPCS mix indicates the practice operates as a high-volume biologics/infusion site despite a Family Medicine Physician taxonomy: dominant codes are biologic injectables (J3245, J0517, J2357) and multiple immune globulin products (J1561, J1568, J1569), alongside frequent infusion administration codes (96365, 96366, 96372). This combination points to on‑site administration of specialty injectables and infusion therapies rather than a pure office‑visit primary care model.

Competitive standing varies by product: J0517 ranks #7 of 200 providers nationally at the 97th percentile and J2357 ranks #36 of 581 at the 94th percentile, both described as "notably above typical national volume," indicating a major national presence for benralizumab and omalizumab administration. By contrast, J3245 (rank #37 of 225, 83th percentile) is characterized as typical/unremarkable volume, so the provider is a market leader for some biologics but not across all top agents.

Operational throughput is evident in several high‑claim, low‑unit‑price products: J0256 shows 99.8K claims at $4 avg paid/claim for $399.2K revenue (rank #3 of 12, 82th percentile; labeled typical/unremarkable volume). The very large claim count with a low average payment suggests routine, frequent administration processes (high patient visits or repeated dosing) and the capacity to deliver many small‑unit therapies.

Administration and infusion procedure codes are statistical outliers versus peers, supporting the infusion-site interpretation: 96365 (728 claims, $33.5K revenue) ranks #178 of 8873 providers at the 98th percentile and 96372 (710 claims, $7.8K revenue) ranks #852 of 58224 providers at the 99th percentile, both described as "notably above typical national volume." 96366 is similarly elevated (641 claims, $9.6K revenue; rank #114 of 2976, 96th percentile), indicating frequent IV and injection administrations relative to national peers.

Other biologic and immune therapies also contribute meaningfully to Medicare revenue: J3380 ($357K, 9.2%) and the trio of immune globulin codes J1561 ($283.4K, 7.3%), J1568 ($249.9K, 6.4%), and J1569 ($205.8K, 5.3%) together represent sizable, diversified specialty drug revenue streams. These mid‑level contributors reduce single‑product concentration risk but reinforce that the practice’s financials are driven by specialty biologic and immunomodulatory therapies rather than routine primary‑care E/M services.

The provider has a long billing history, with NPI enumerated on 2006-04-26 (~20 years ago), which suggests an established operating footprint; coupled with the specialized infusion/biologic mix and high national ranks on select agents, this profile looks like a long‑standing practice that has shifted substantial activity toward specialty drug administration under Medicare. Historical tenure plus the current code mix imply stability in service lines, which is important context for contracting or network decisions.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

23 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3245	Injection, tildrakizumab, 1 mg	6,900	$110	$759K
J0517	Injection, benralizumab, 1 mg	3,870	$130	$510.8K
J2357	Injection, omalizumab, 5 mg	15,750	$30	$472.5K
J0256	Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg	99,800	$1	$399.2K
J3380	Injection, vedolizumab, intravenous, 1 mg	21,000	$20	$357K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	7,460	$40	$283.4K
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	7,350	$30	$249.9K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	5,720	$40	$205.8K
J2182	Injection, mepolizumab, 1 mg	7,000	$20	$161K
J2356	Injection, tezepelumab-ekko, 1 mg	10,500	$10	$147K

Showing 1–10 of 23

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. South Carolina Distribution

Stephen Parks — 7 of 23 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — South Carolina

Full comparison — all codes billed, vs. state median

23 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	2	20	3,800	$110	$435.3K
J3380	6	20	11,400	$20	$231K
J2357	2	30	4,360	$30	$183.8K
J0517	1	20	1,100	$130	$180.6K
J1569	5	20	3,860	$40	$161.4K
J1568	1	10	5,220	$30	$155.1K
J2182	5	10	5,050	$20	$146.9K
J1561	1	10	3,890	$40	$146.6K
J0256	1	10	33,660	$1	$141.1K
J2356	2	10	7,140	$10	$109.9K

Showing 1–10 of 23

Related Providers

Other providers that share a Tax Identification Number (TIN) with Stephen Parks, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Palmetto Infusion Services LLC	SC	Infusion Therapy Clinic/Center	$0	$93.6M
Doctors Care, PA	SC	Family Medicine Physician	$0	$50.7M
Kristi Hunter	GA	General Practice Physician	$6.4M	$0
Rachel Tedesco	NC	Nurse Practitioner	$5.7M	$0
Lindsay Gamble	SC	Family Nurse Practitioner	$3.7M	$0
Lisa Sauls	SC	Family Nurse Practitioner	$3.4M	$0
Rosalee Unwin	SC	Family Nurse Practitioner	$2.9M	$0
Whitley Weatherford	SC	Family Nurse Practitioner	$2.7M	$0
Glenda Collins	SC	Family Nurse Practitioner	$2.3M	$0
Kalpesh Purohit	SC	Family Medicine Physician	$2.1M	$0

Nearby Providers

Other providers in the same ZIP code as Stephen Parks, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Minuteclinic Diagnostic South Carolina LLC	SC	Family Nurse Practitioner	$0	$3.8M
Tribe Dental LLC	SC	Pediatric Dentistry	$0	$1.9M
Krishi Peddada	SC	Ophthalmology Physician	$1.3M	$0
Adam Easterling	SC	Ophthalmology Physician	$384.2K	$0
James Mcalpine	SC	Internal Medicine Physician	$122.6K	$0
Sydney Vanbeek	SC	Occupational Therapist	$92.3K	$0
Mary Gillingham	SC	Family Nurse Practitioner	$36.3K	$0
Rachel Langenfeld	SC	Physician Assistant	$13.2K	$0

Stephen Parks — Billing Profile & Reimbursement Data

Sign up for Stephen Parks — Billing Profile & Reimbursement Data policy alerts

Stephen Parks — Billing Profile & Reimbursement Data

Sign up for Stephen Parks — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References